Eledon Pharmaceuticals (ELDN) EPS (Basic) (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted EPS (Basic) of -$0.19 for Q1 2026, up 26.48% on a QoQ basis from -$0.26 in Q3 2025, and down 143.32% year-over-year from $0.44 in Q1 2025.
Eledon Pharmaceuticals (ELDN) EPS (Basic) (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' EPS (Basic) history runs 14 years deep, the most recent figure standing at -$0.19 for Q1 2026.
- Quarterly EPS (Basic) fell 143.32% year-over-year to -$0.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.59 (up 3.26% YoY) and the FY2025 annual result came in at -$0.52, up 21.52% from the prior year.
- EPS (Basic) was -$0.19 for Q1 2026 at Eledon Pharmaceuticals, up from -$0.26 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.13 in Q3 2024 and bottomed at -$4.09 in Q4 2022.
- A 5-year average of -$0.66 and a median of -$0.44 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 587.8% — and 2024, when it surged 132.92%.
- Eledon Pharmaceuticals' EPS (Basic) stood at -$4.09 in 2022, then surged by 89.63% to -$0.42 in 2023, then sank by 59.6% to -$0.68 in 2024, then jumped by 61.95% to -$0.26 in 2025, then rose by 26.48% to -$0.19 in 2026.
- Business Quant data shows ELDN's EPS (Basic) at -$0.19 in Q1 2026, -$0.26 in Q3 2025, and -$0.33 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | 0.00 |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn | 1.55 |
| 10 | Eledon Pharmaceuticals | 400.23 Mn | 400.23 Mn | - | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.19 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.33 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.68 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | -0.36 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.42 |
| Sep 30, 2023 | -0.39 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -0.78 |
| Dec 31, 2022 | -4.09 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -0.66 |
| Jun 30, 2021 | -0.50 |
| Mar 31, 2021 | -0.57 |